TANDY LEATHER FACTORY INC
For the period ended Sep 30, 2026. Filed Nov 10, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Condensed Consolidated Financial Statements (Unaudited)
| Item 1. | Condensed Consolidated Financial Statements |
|---|
Condensed Consolidated Balance Sheets
(amounts in thousands, except share data and per share data)
| September 30, | December 31, | |
|---|---|---|
| 2026 | 2025 | |
| (Unaudited) | ||
| ASSETS | ||
| CURRENT ASSETS: | ||
| Cash and cash equivalents | $5,727 | $16,087 |
| Accounts receivable-trade, net of allowance for credit losses of $51 at September 30, 2026 and December 31, 2025 | 383 | 425 |
| Inventory | 37,509 | 33,238 |
| Prepaid expenses | 913 | 721 |
| Other current assets | 108 | 111 |
| Total current assets | 44,640 | 50,582 |
| Property and equipment, at cost | 27,603 | 26,203 |
| Less accumulated depreciation | (16,887) | (15,978) |
| Property and equipment, net | 10,716 | 10,225 |
| Operating lease assets | 25,497 | 24,736 |
| Deferred income taxes | 347 | 380 |
| Other assets | 731 | 710 |
| TOTAL ASSETS | $81,931 | $86,633 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| CURRENT LIABILITIES: | ||
| Accounts payable-trade | $2,090 | $2,154 |
| Accrued expenses and other liabilities | 3,375 | 3,704 |
| Income taxes payable | 92 | 428 |
| Current portion of operating lease liabilities | 3,960 | 3,512 |
| Total current liabilities | 9,517 | 9,798 |
| Uncertain tax positions | 227 | 227 |
| Other non-current liabilities | 148 | 149 |
| Operating lease liabilities, non-current | 24,522 | 23,868 |
| COMMITMENTS AND CONTINGENCIES (Note 7) | ||
| STOCKHOLDERS’ EQUITY: | ||
| Common stock, $0.0024 par value; 15,000,000 shares authorized; 9,616,451 and 9,497,251 shares issued at September 30, 2026 and December 31, 2025, respectively; 8,192,075 and 8,072,875 shares outstanding at September 30, 2026 and December 31, 2025, respectively | 22 | 22 |
| Paid-in capital | 3,766 | 3,651 |
| Retained earnings | 55,892 | 60,843 |
| Treasury stock at cost (1,424,376 shares at September 30, 2026 and December 31, 2025) | (9,773) | (9,773) |
| Accumulated other comprehensive loss, net of tax | (2,390) | (2,152) |
| Total stockholders’ equity | 47,517 | 52,591 |
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $81,931 | $86,633 |
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
(amounts in thousands, except share and per share data)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Net sales | $18,522 | $17,264 | $56,218 | $54,072 |
| Cost of sales | 6,969 | 7,094 | 20,978 | 22,612 |
| Gross profit | 11,553 | 10,170 | 35,240 | 31,460 |
| Operating expenses | 10,997 | 10,848 | 33,777 | 31,811 |
| Income (loss) from operations | 556 | (678) | 1,463 | (351) |
| Other income (expense): | ||||
| Interest income | 26 | 98 | 201 | 461 |
| Gain on disposal of headquarters | - | 16,225 | ||
| Other, net | (7) | (1,253) | (100) | (2,946) |
| Total other income (loss) | 19 | (1,155) | 101 | 13,740 |
| Income (loss) before income taxes | 575 | (1,833) | 1,564 | 13,389 |
| Income tax provision (benefit) | 102 | (481) | 460 | 3,357 |
| Net income (loss) | $473 | $(1,352) | $1,104 | $10,032 |
| Foreign currency translation adjustments, net of tax | 69 | (235) | (238) | 70 |
| Comprehensive income (loss) | $542 | $(1,587) | $866 | $10,102 |
| Net income (loss) per common share: | ||||
| Basic | $0.06 | $(0.17) | $0.14 | $1.20 |
| Diluted | $0.06 | $(0.17) | $0.14 | $1.18 |
| Weighted average number of shares outstanding: | ||||
| Basic | 8,192,075 | 8,142,441 | 8,150,039 | 8,378,083 |
| Diluted | 8,192,524 | 8,142,441 | 8,150,039 | 8,502,787 |
Condensed Consolidated Statements of Cash Flows
(amounts in thousands)
| For the Nine Months Ended September 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash flows from operating activities: | ||
| Net income | $1,104 | $10,032 |
| Adjustments to reconcile net income to net cash used in operating activities: | ||
| Depreciation and amortization | 853 | 609 |
| Operating lease asset amortization | 4,061 | 3,915 |
| Gain on disposal of assets | - | (16,225) |
| Stock-based compensation | 253 | 338 |
| Deferred income taxes | 32 | 1,043 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable-trade | 40 | 30 |
| Inventory | (4,474) | (191) |
| Prepaid expenses | (192) | (186) |
| Other current assets | 3 | 12 |
| Accounts payable-trade | (63) | (815) |
| Accrued expenses and other liabilities | (325) | (897) |
| Income taxes, net | (335) | 716 |
| Other assets | (23) | (190) |
| Operating lease liabilities | (3,722) | (3,727) |
| Total adjustments | (3,892) | (15,568) |
| Net cash used in operating activities | (2,788) | (5,536) |
| Cash flows from investing activities: | ||
| Purchase of property and equipment | (1,351) | (6,590) |
| Proceeds from sales of Headquarter assets, net | - | 24,897 |
| Net cash provided by (used in) investing activities | (1,351) | 18,307 |
| Cash flows from financing activities: | ||
| Dividend Paid | (6,055) | (12,745) |
| Withholding of vested stock for employee tax | (137) | (1,470) |
| Net cash used in financing activities | (6,192) | (14,215) |
| Effect of exchange rate changes on cash and cash equivalents | (29) | 191 |
| Net decrease in cash and cash equivalents | (10,360) | (1,253) |
| Cash and cash equivalents, beginning of period | 16,087 | 13,271 |
| Cash and cash equivalents, end of period | $5,727 | $12,018 |
Condensed Consolidated Statements of Stockholders’ Equity
(amounts in thousands, except share data)
| Number of Shares Common Stock Outstanding | Par Value | Paid-in Capital | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Total | |
|---|---|---|---|---|---|---|---|
| Balance, December 31, 2025 | 8,072,875 | $22 | $3,651 | $(9,773) | $60,843 | $(2,152) | $52,591 |
| Stock-based compensation expense | - | - | 93 | - | - | - | 93 |
| Vesting of restricted stock units | 117,776 | - | - | - | - | - | - |
| Repurchase of common stock | - | - | - | - | - | - | - |
| Net income | - | - | - | - | 222 | - | 222 |
| Dividend Paid | - | - | - | - | (6,055) | - | (6,055) |
| Withholding of vested stock for employee tax | (47,082) | - | (137) | - | - | - | (137) |
| Foreign currency translation adjustments, net of tax | - | - | - | - | - | (212) | (212) |
| Balance, March 31, 2026 | 8,143,569 | $22 | $3,607 | $(9,773) | $55,010 | $(2,364) | $46,502 |
| Stock-based compensation expense | - | - | 141 | - | - | - | 141 |
| Vesting of restricted stock units | 48,506 | - | - | - | - | - | - |
| Repurchase of common stock | - | - | - | - | - | - | - |
| Net income | - | - | - | - | 409 | - | 409 |
| Dividend Paid | - | - | - | - | - | - | - |
| Withholding of vested stock for employee tax | - | - | - | - | - | - | - |
| Foreign currency translation adjustments, net of tax | - | - | - | - | - | (95) | (95) |
| Balance, June 30, 2026 | 8,192,075 | 22 | 3,748 | (9,773) | 55,419 | (2,459) | 46,957 |
| Stock-based compensation expense | - | - | 19 | - | - | - | 19 |
| Vesting of restricted stock units | - | - | - | - | - | - | - |
| Repurchase of common stock | - | - | - | - | - | - | - |
| Net income | - | - | - | - | 473 | - | 473 |
| Dividend Paid | - | - | - | - | - | - | - |
| Withholding of vested stock for employee tax | - | - | - | - | - | - | - |
| Foreign currency translation adjustments, net of tax | - | - | - | - | - | 69 | 69 |
| Balance, September 30, 2026 | 8,192,075 | 22 | 3,766 | (9,773) | 55,892 | (2,390) | 47,517 |
| Balance, December 31, 2024 | 8,496,581 | $23 | $4,529 | $(9,773) | $64,486 | $(2,112) | 57,153 |
| Stock-based compensation expense | - | - | 93 | - | - | - | 93 |
| Vesting of restricted stock units | 15,973 | - | - | - | - | - | - |
| Net income | - | - | - | - | 11,583 | - | 11,583 |
| Dividend Paid | - | - | - | - | (12,745) | - | (12,745) |
| Foreign currency translation adjustments, net of tax | - | - | - | - | - | (288) | (288) |
| Balance, March 31, 2025 | 8,512,554 | $23 | $4,622 | $(9,773) | $63,324 | $(2,400) | $55,796 |
| Stock-based compensation expense | - | - | 118 | - | - | - | 118 |
| Vesting of restricted stock units | 3,078 | - | - | - | - | - | - |
| Repurchase of common stock | (17,233) | - | (176) | - | - | - | (176) |
| Net loss | - | - | - | - | (199) | - | (199) |
| Dividend Paid | - | - | - | - | - | - | - |
| Foreign currency translation adjustments, net of tax | - | - | - | - | - | 593 | 593 |
| Balance, June 30, 2025 | 8,498,399 | 23 | 4,564 | (9,773) | 63,125 | (1,807) | 56,132 |
| Stock-based compensation expense | - | - | 127 | - | - | - | 127 |
| Vesting of restricted stock units | - | - | - | - | - | - | - |
| Repurchase of common stock | (430,987) | (1) | (1,293) | - | - | - | (1,294) |
| Net loss | - | - | - | - | (1,352) | - | (1,352) |
| Foreign currency translation adjustments, net of tax | - | - | - | - | - | (235) | (235) |
| Balance, September 30, 2025 | 8,067,412 | 22 | 3,398 | (9,773) | 61,773 | (2,042) | 53,378 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.